Immunova to Acquire AlphaTON Subsidiary Iox Therapeutics
Immunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
Understanding when points offer greater value than cash back can enhance your credit card strategy. Discover these key moments.
28,161 articlesImmunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
Microsoft rolled out a fresh coding AI family at Build, aiming to accelerate developer tooling. Investors will watch ...
A look at five 2016 IPOs shows how a $1,000 investment in each would have fared through 2026, highlighting divergent ...
Oracle confronts a fresh wave of investor anxiety as a heavy OpenAI backlog, negative cash flow, and mounting leverag...
In March 2026, investors seek cost-efficient, user-friendly options beyond M1 Finance. This report breaks down the to...
SpaceX’s market cap vaults above $3 trillion, turning a $60 billion Cursor acquisition into a relative rounding error...
The Federal Reserve’s March meeting is drawing intense scrutiny as markets weigh potential rate moves amid signs that...
In early 2026, women surpassed men in U.S. nonfarm payrolls, signaling a structural shift. This story explores the st...
This average social security is a key piece of retirement planning. In 2026, the typical 67-year-old can expect to re...
When headlines spotlight a celebrity living abroad, it raises practical questions about how such a move affects money...
A new wave of institutional capital is driving Ethereum’s next leg higher, with BlackRock and JPMorgan expanding on-c...
The Senate Banking Committee moved the CLARITY Act forward, setting the stage for a broader battle over crypto regula...